Drug Database
Back to search

United States· US:70518-3847_3f8bc3b1-e61e-9f63-e063-6294a90a021a

Hyoscyamine Sulfate TAB

A hyoscyamine product containing hyoscyamine sulfate, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 3 of our 19 countries.

ATC A03BA03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHyoscyamine Sulfate TABATCA03BA03REGISTER NO.US:70518-3847_3f8bc3b…PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hyoscyamine sulfateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Hyoscyamine is registered in 3 of 19 countries.

Countries holding a registration under ATC A03BA03 (hyoscyamine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose
Search hyoscyamine products by name

Hyoscyamine · ATC A03BA03

3 / 19 countries

  • Finlandprice
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
hyoscyamine sulfate
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
A03BA03
ATC class
Hyoscyamine
Defined daily dose
1.2 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    7051838471
    180 TABLET in 1 BOTTLE, PLASTIC (70518-3847-1)

Regulatory notes

UNII (FDA substance ID)
F2R8V82B84
HYOSCYAMINE SULFATE
RxCUI 1225
DailyMed SPL labels
1 version tracked

Interactions

217 interactions on record for hyoscyamine.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check hyoscyamine against other medicinesHow interaction checks work

Hyoscyamine · interactions on record

217 records

  • 6 severe
  • 194 moderate
  • 17 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Hyoscyamine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hyoscyamine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/665d59f3-c67a-4653-aab2-bb2b097a6082
GET /v1/drugs/665d59f3-c67a-4653-aab2-bb2b097a6082?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "F2R8V82B84",
    "rxcui": "1225",
    "inchikey": "BXSVDJUWKSRQMD-ITMJLNKNSA-N",
    "display_name": "HYOSCYAMINE SULFATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "51a07955-485f-1357-e063-6394a90ad3f8": {
      "match": "brand_token",
      "title": "HYOSCYAMINE SULFATE TABLET, ORALLY DISINTEGRATING [PD-RX PHARMACEUTICALS, INC.]",
      "spl_version": "2",
      "published_date": "2026-05-13"
    }
  },
  "productid": "70518-3847_3f8bc3b1-e61e-9f63-e063-6294a90a021a",
  "productndc": "70518-3847",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "HYOSCYAMINE SULFATE",
  "proprietary_name": "Hyoscyamine Sulfate TAB",
  "active_ingred_unit": "mg/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER",
  "nonproprietary_name": "hyoscyamine sulfate",
  "start_marketing_date": "20230831",
  "active_numerator_strength": ".125"
}
API referenceMCP serverPlans

See everything about hyoscyamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console